Carmona Echeverria, Lina Maria
Haider, Aiman
Freeman, Alex
Stopka-Farooqui, Urszula
Rosenfeld, Avi
Simpson, Benjamin S.
Hu, Yipeng
Hawkes, David
Pye, Hayley
Heavey, Susan
Stavrinides, Vasilis
Norris, Joseph M.
Bosaily, Ahmed El-Shater
Cardona Barrena, Cristina
Bott, Simon
Brown, Louise
Burns-Cox, Nick
Dudderidge, Tim
Henderson, Alastair
Hindley, Richard
Kaplan, Richard
Kirkham, Alex
Oldroyd, Robert
Ghei, Maneesh
Persad, Raj
Punwani, Shonit
Rosario, Derek
Shergill, Iqbal
Winkler, Mathias
Ahmed, Hashim U.
Emberton, Mark
Whitaker, Hayley C.
Funding for this research was provided by:
Prostate Cancer UK (CEO13_2-002, PG14-018-TR2, LD-PF16-004)
Rosetrees Trust (A1383)
Medical Research Council (MR/S005897/1, MR/S00680X/1, MC_UU_12023/28)
Article History
Received: 30 April 2020
Accepted: 28 August 2020
First Online: 14 October 2020
Competing interests
: Ahmed currently receives funding from the Wellcome Trust, Prostate Cancer UK, Medical Research Council (UK), Cancer Research UK, The Urology Foundation, BMA Foundation, Imperial Healthcare Charity, Sonacare Inc., Trod Medical and Sophiris Biocorp for trials in prostate cancer. Ahmed is a paid medical consultant for Sophiris Biocorp, Sonacare Inc., BTG and Boston for trials work and proctoring. Emberton receives funding from NIHR-i4i, MRC, Cancer Research UK, Sonacare Inc., and Sophiris Biocorp for trials in prostate cancer. Emberton is a medical consultant to Sonacare Inc., Sophiris Biocorp, Steba Biotech, Exact Imaging and Profound Medical. Ahmed and Emberton are proctors for HIFU and paid for training other surgeons in this procedure. Ahmed is a proctor for cryotherapy using the Galil/BTG system. Emberton is a proctor for Irreversible Electroporation (Nanoknife). Rest of the authors have no conflict of interest.